Regulatory Story
Go to market news section View chart   Print
The MedicX Fund Limited  -  MXF   

Further re Notice of dividend

Released 18:22 06-Feb-2013

RNS Number : 3167X
The MedicX Fund Limited
06 February 2013



Press Release

For immediate release                                                                                    

6 February 2013


MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")


Correction announcement - Notice of dividend


The following amendment has been made to the "Notice of Dividend" announcement released on 1 February 2013 at 12:31 hrs under RNS No 9404W:


The Notice of Dividend announcement released on 1 February 2013 incorrectly noted that payment in respect of the dividend for the period 1 October 2012 to 31 December 2012 (the "March dividend") will be made on 29 March 2013.


Given that 29 March 2013 is a bank holiday, the March dividend will be paid on 28 March 2013, and this date will be reflected in all future announcements concerning the March dividend.


All other details remain unchanged.







For further information please contact:


MedicX Group                                                                 +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer


Canaccord Genuity Limited                                                 +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith


Buchanan Communications                                              +44 (0) 20 7466 5000

Charles Ryland/Gabriella Clinkard


MedicX Fund Limited                                                       +44 (0) 1481 723 450

David Staples, Chairman




Information on MedicX Fund Limited


MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 107 properties.


The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  


The Company's website address is www.medicxfund.comNeither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Further re Notice of dividend - RNS